F13.251
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.251 refers to a condition where an individual develops a dependence on sedatives, hypnotics, or anxiolytic medications, accompanied by a psychotic disorder characterized by hallucinations. This diagnosis highlights the complex relationship between medication dependency and mental health issues, emphasizing the importance of appropriate management and awareness.
Causes & Symptoms
Clinical Causes: Extended use of sedatives, hypnotics, or anxiolytics beyond recommended durations, leading to dependence. Self-medication or misuse of prescriptions to manage stress, anxiety, or sleep problems. Underlying mental health conditions that predispose individuals to medication reliance. Availability and accessibility of sedative or anxiolytic medications without proper medical supervision. Poor adherence to prescribed dosages and potential for overdose or abuse.
Key Symptoms: Hallucinations, often visual or auditory, occurring during periods of dependence. Craving and strong desire to continue medication use despite adverse effects. Difficulty controlling or reducing medication intake. Psychotic behaviors such as paranoia, delusions, or agitation. Withdrawal symptoms when attempting to stop or reduce medication use, including anxiety, tremors, or insomnia. Changes in mood, including depression or irritability.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive assessment by a healthcare professional, considering medical history, medication use patterns, and symptom presentation. Mental health evaluations and physical examinations may be conducted, alongside reviewing medication records. Diagnostic criteria for substance dependence and psychotic features are used to confirm the condition.
Treatment Protocols: Treatment approaches focus on managing both medication dependence and psychotic symptoms. Interventions may include: - **Detoxification:** supervision during withdrawal to minimize adverse effects. - **Medication management:** using other medications to stabilize mental health issues and reduce dependency. - **Psychotherapy:** counseling methods such as cognitive-behavioral therapy (CBT) to address underlying causes and support recovery. - **Support groups:** peer support to foster adherence and emotional coping. - **Monitoring:** regular follow-up to prevent relapse and manage ongoing symptoms. A multidisciplinary approach involving medical, psychiatric, and social support professionals is essential for effective management.
Clinical Advice & FAQs
Billing Guidance
Is F13.251 a billable ICD-10 code?
Yes, F13.251 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.251?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference